0:00
24:51
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
Altri episodi di "AAAAI Podcast: Conversations from the World of Allergy"
Non perdere nemmeno un episodio di “AAAAI Podcast: Conversations from the World of Allergy”. Iscriviti all'app gratuita GetPodcast.